Oxaliplatin, Capecitabine, and Cetuximab in Treating Patients With Advanced Liver Cancer

NCT00483405 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

33

Enrollment

OTHER

Sponsor class

Conditions

Liver Cancer

Interventions

BIOLOGICAL: cetuximab
DRUG: capecitabine
DRUG: oxaliplatin

Sponsor

UNC Lineberger Comprehensive Cancer Center

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]